Yanming Wang

This inventor holds 19 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Molecular Imaging. Top assignees: University of Pittsburgh, Case Western Reserve University. Active years: 2007-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yanming Wang. Retrieved from https://idiyas.com/inventor/yanming-wang-57g1mlky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 4)

% Patents Active = 63.2

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 70(Granted Patents)

Location History:

Imperial, PA (US) (2007 - 2014)
Cleveland, OH (US) (2019)
Beachwood, OH (US) (2013 - 2023)

Company Filing History:

11 out of 1,960

University of Pittsburgh

patents

8 out of 1,364

Case Western Reserve University

patents

Years Active: 2007-2023

Loading Chart...

Areas of Expertise:

Molecular Probes

Radioligands

Thioflavin Derivatives

Alzheimer's Disease

In Vivo Imaging

Myelin Detection

Benzothiazole Compounds

Amyloid Deposition

Fluorescent Probes

Abasic Site Detection

Peripheral Nervous System

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11801315 - Radioligands for myelin (2023-10-31),

2. 11382991 - Molecular probes for imaging of myelin (2022-07-12),

3. 10765763 - Radioligands for myelin (2020-09-08),

4. 10718028 - Fluorescent probes for abasic site detection (2020-07-21),

5. 10350308 - Molecular probes for imaging myelin (2019-07-16),

6. 10137210 - Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition (2018-11-27),

7. 9987379 - Molecular probes for imaging of myelin (2018-06-05),

8. 9833458 - Thioflavin derivatives for use in the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition (2017-12-05),

9. 9808541 - Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition (2017-11-07),

10. 9555130 - Compositions and methods for in vivo imaging of myelin in the peripheral nervous system (2017-01-31),

11. 9134328 - Methods of using benzothiazole derivative compounds and compositions (2015-09-15),

12. 8911707 - Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition (2014-12-16),

13. 8691185 - Benzothiazole derivative compounds, compositions and uses (2014-04-08),

14. 8404213 - Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition (2013-03-26),

15. 8367332 - Detection and quantification of abasic site formation in vivo (2013-02-05),

Title: The Innovations of Yanming Wang

Introduction

Yanming Wang, based in Beachwood, OH, is an accomplished inventor and researcher with an impressive portfolio of 19 patents. His work primarily focuses on radioligands and molecular probes that significantly contribute to the field of myelin imaging. His innovative approach in developing tools for neuroscience research has made a substantial impact on the understanding of myelin in the central nervous system.

Latest Patents

Among Yanming Wang's latest patents are two significant inventions: "Radioligands for Myelin," which details a radioligand for labeling myelin that includes a fluorescent trans-stilbene derivative, and "Molecular Probes for Imaging of Myelin," which also incorporates a fluorescent trans-stilbene derivative for labeling myelin. These patents underscore his contributions to the enhancement of imaging techniques in neuroscience.

Career Highlights

Throughout his career, Yanming has worked with prestigious institutions, including the University of Pittsburgh and Case Western Reserve University. His affiliation with these universities has allowed him to collaborate with top experts and foster an environment of innovation and research in the realm of myelin imaging.

Collaborations

Yanming Wang has had the privilege of collaborating with renowned professionals in his field, including William E. Klunk and Chester A. Mathis, Jr. These partnerships have not only enhanced his research capabilities but have also facilitated the advancement of critical projects related to neuroscience and imaging technologies.

Conclusion

In conclusion, Yanming Wang represents a remarkable force in the field of invention and innovation, particularly in the area of myelin research. His 19 patents reflect his dedication to advancing scientific knowledge and improving medical imaging techniques, showcasing his significant contributions to neuroscience. His innovative work continues to inspire fellow researchers and pave the way for future developments in the field.

Profile summary based on public USPTO records.